Compass Therapeutics Inc. (CMPX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.46
0.46 (23.00%)
At close: Jan 15, 2025, 3:59 PM
2.36
-3.98%
After-hours Jan 15, 2025, 04:32 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -4.66 | -14.38 | -2.41 | -8.87 | -12.75 | -11.57 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.33 | 2.91 | 1.42 | 6.55 | -3.73 | -5.23 |
P/FCF Ratio | -4.88 | -15.41 | -9.39 | -9.72 | -13.75 | -12.41 |
P/OCF Ratio | -4.88 | -15.5 | -10.13 | -9.76 | -13.96 | -13.15 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.02 | 0.03 | 0.23 | -0.13 | -0.17 |
Quick Ratio | 19.73 | 12.05 | 13.84 | 4.97 | 2.67 | 6.96 |
Current Ratio | 19.73 | 12.05 | 13.84 | 4.97 | 2.67 | 6.96 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -17.65 | -221.3 | -30.63 | -27.73 | -49.95 |
Return on Equity (ROE) | -0.29 | -0.2 | -0.59 | -0.74 | 0.29 | 0.45 |
Return on Assets (ROA) | -0.27 | -0.18 | -0.54 | -0.57 | -1.14 | -0.59 |
Return on Capital (ROIC) | -0.34 | -0.23 | -0.57 | -0.67 | -1.66 | -0.68 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |